Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 10.14% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.98
Flat results in Sep 25
Risky - Negative EBITDA
Underperformed the market in the last 1 year
Stock DNA
Commodity Chemicals
INR 21 Cr (Micro Cap)
110.00
39
0.00%
-0.46
1.35%
1.48
Total Returns (Price + Dividend) 
Latest dividend: 0.1800 per share ex-dividend date: Oct-29-2009
Risk Adjusted Returns v/s 
Returns Beta
News

Jayshree Chemicals Stock Falls to 52-Week Low of Rs.5.9 Amidst Market Pressures
Jayshree Chemicals has reached a new 52-week low of Rs.5.9, marking a significant decline in its stock price amid a challenging market environment. This level reflects a substantial drop from its 52-week high of Rs.12, underscoring the pressures faced by the company within the commodity chemicals sector.
Read More
Jayshree Chemicals Falls to 52-Week Low of Rs.5.99 Amidst Market Rally
Jayshree Chemicals has reached a new 52-week low of Rs.5.99 today, marking a significant decline in its share price despite a broadly positive market environment. The stock underperformed its sector and the broader indices, reflecting ongoing concerns about the company’s financial health and market position.
Read More
Jayshree Chem. Sees Revision in Market Evaluation Amidst Challenging Fundamentals
Jayshree Chem., a microcap player in the Commodity Chemicals sector, has experienced a notable revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. This adjustment highlights ongoing challenges in the company’s financial and operational performance, which have influenced investor sentiment and stock returns over recent periods.
Read More Announcements 
Maintenance Of Books Of Accounts & Statutory Register
10-Nov-2025 | Source : BSEPursuant to Regulation 30 of SEBI LODR Regulations 2015 we would like to inform you that the Board of Directors at its meeting held on 10th November 2025 has decided to keep and maintain the Books of Accounts and Statutory Registers of the Company at the Corporate office of the Company situate at 31 Chowringhee Road Kolkata 700016 apart from maintaining the same at the Registered office of the Company
Board Meeting Outcome for Outcome Of Board Meeting Held On 10.11.2025
10-Nov-2025 | Source : BSEOutcome of the Board Meeting held on 10th November 2025
Board Meeting Intimation for NOTICE OF BOARD MEETING
04-Nov-2025 | Source : BSEJayshree Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and 33(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Notice is hereby given that a Meeting of the Board of Directors of the Company will be held through Video Conference on Monday 10th November 2025 to consider and approve inter-alia the Un-Audited Financial Results of the Company for the quarter and half-year ended on 30th September 2025. Further as informed by our above referred letter dated 26th September 2025 the trading window for dealing in securities of the Company was closed from 1st October 2025 and shall remain closed till 48 hours after the announcement of financial results i.e. upto 12th November 2025 (both days inclusive).
Corporate Actions 
No Upcoming Board Meetings
Jayshree Chemicals Ltd has declared 10% dividend, ex-date: 29 Oct 09
No Splits history available
No Bonus history available
Jayshree Chemicals Ltd has announced 9:2 rights issue, ex-date: 17 Feb 10
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 1 Schemes (0.0%)
Held by 0 FIIs
Veer Enterprises Ltd (10.71%)
Shaunak Jagdish Shah (4.47%)
49.88%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 15.37% vs 1.68% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 600.00% vs 87.50% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 22.12% vs 21.30% in Sep 2024
Growth in half year ended Sep 2025 is 300.00% vs -95.00% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is 28.00% vs 52.84% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -152.38% vs 275.00% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 26.29% vs 43.24% in Mar 2024
YoY Growth in year ended Mar 2025 is 92.31% vs -2,825.00% in Mar 2024






